Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |